Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
2
×
life sciences
national blog main
new york blog main
azacitidine
beta-thalassemia
cancer
clinical trials
codiak biosciences
cutaneous t-cell lymphoma
dacogen
deals
decitabine
dna
epigenetics
epizyme
exosome
farydak
flagship pioneering
fulcrum therapeutics
insulated genomic domains
jazz pharmaceuticals
kaleido biosciences
mahesh karande
national top stories
new york top stories
omega therapeutics
panobinostat
richard young
robert gould
rudolf jaenisch
san francisco blog main
san francisco top stories
sarepta therapeutics
sickle cell disease
startups
syros pharmaceuticals
What
based
2
×
medicines
2
×
new
aims
approach
begin
biosciences
biotech
bio’s
brings
bubbles
called
cells
class
clinical
codiak
debuts
developing
drugs
epigenetic
epigenetics
exosome
exosomes
field
flagship’s
formed
fund
ipo
million
morning
omega
research
startup
step
tests
therapeutics
tiny
touting
trials
Language
unset
Current search:
medicines
×
based
×
" boston top stories "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
